Emily Rollins - 01 Mar 2023 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role
Director
Signature
/s/ Daniel Rodriguez, as Attorney-in-Fact for Emily Rollins
Issuer symbol
DLB
Transactions as of
01 Mar 2023
Net transactions value
-$82,040
Form type
4
Filing time
03 Mar 2023, 16:19:38 UTC
Previous filing
09 Feb 2023
Next filing
23 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Sale $82,040 -1,000 -13% $82.04 6,541 01 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held following the reported transactions include 3,296 restricted stock units, which are subject to forfeiture until they vest.

Remarks:

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.